scispace - formally typeset
G

George J. Poiani

Researcher at Rutgers University

Publications -  11
Citations -  682

George J. Poiani is an academic researcher from Rutgers University. The author has contributed to research in topics: Pulmonary hypertension & Hypoxia (medical). The author has an hindex of 8, co-authored 11 publications receiving 513 citations. Previous affiliations of George J. Poiani include Robert Wood Johnson University Hospital & United States Department of Veterans Affairs.

Papers
More filters
Journal ArticleDOI

An Update on Current Therapeutic Drugs Treating COVID-19.

TL;DR: It is hoped that this review will provide useful and most updated therapeutic drugs to prevent, control, and treat COVID-19 patients until the approval of vaccines and specific drugs targeting SARS-CoV-2.
Journal ArticleDOI

Colchicine to Weather the Cytokine Storm in Hospitalized Patients with COVID-19.

TL;DR: Patients receiving colchicine were approximately five times more likely to be discharged than those receiving standard of care at the end of the 28 day follow-up, and these observations warrant further investigation in large controlled clinical trials.
Journal ArticleDOI

Pharmacokinetics, Pharmacodynamics, and PKPD Modeling of Curcumin in Regulating Antioxidant and Epigenetic Gene Expression in Healthy Human Volunteers.

TL;DR: The results show that the bioavailability of the parent curcumin compound is low, and oral administration ofCurcumin can still deliver detectable levels of curCumin glucuronide metabolite, and antioxidant and epigenetic effects which could contribute to the overall health beneficial effects of Curcumin are elicited.
Patent

Polymer compositions comprising antifibrotic agents, and methods of treatment, pharmaceutical compositions, and methods of preparation therefor

TL;DR: In this article, a method for treating pulmonary hypertension and other diseases involving a defect in collagen metabolism, by administration of an effective amount of a liposome encapsulated copolymer conjugate antifibrotic composition, is disclosed.
Journal ArticleDOI

Recombinant human relaxin reduces hypoxic pulmonary hypertension in the rat.

TL;DR: It is concluded that rhRlx inhibits the early fibroproliferative response in hypoxic pulmonary hypertension and the mechanism may be due in part to suppression of collagen synthesis.